Patents Assigned to SNIPR TECHNOLOGIES LIMITED
-
Publication number: 20190321468Abstract: The invention relates to methods of modulating immune cells in a patient by altering microbiota of the patient. The invention also relates to methods of modulating treatments or therapies in a subject organism by altering microbiota of the subject. The invention also relates to cell populations, systems, arrays, cells, RNA, kits and other means for effecting this. In an example, advantageously selective targeting of a particular species in a human gut microbiota using guided nucleic acid modification is carried out to effect the alteration.Type: ApplicationFiled: June 26, 2019Publication date: October 24, 2019Applicant: SNIPR Technologies LimitedInventor: Jasper CLUBE
-
Publication number: 20190321470Abstract: The invention relates to methods of modulating immune cells in a patient by altering microbiota of the patient. The invention also relates to methods of modulating treatments or therapies in a subject organism by altering microbiota of the subject. The invention also relates to cell populations, systems, arrays, cells, RNA, kits and other means for effecting this. In an example, advantageously selective targeting of a particular species in a human gut microbiota using guided nucleic acid modification is carried out to effect the alteration.Type: ApplicationFiled: June 26, 2019Publication date: October 24, 2019Applicant: SNIPR Technologies LimitedInventor: Jasper CLUBE
-
Publication number: 20190240325Abstract: The invention relates to methods of modulating immune cells in a patient by altering microbiota of the patient. The invention also relates to methods of modulating treatments or therapies in a subject organism by altering microbiota of the subject. The invention also relates to cell populations, systems, arrays, cells, RNA, kits and other means for effecting this. In an example, advantageously selective targeting of a particular species in a human gut microbiota using guided nucleic acid modification is carried out to effect the alteration.Type: ApplicationFiled: April 19, 2019Publication date: August 8, 2019Applicant: SNIPR Technologies LimitedInventor: Jasper Clube
-
Publication number: 20190240326Abstract: The invention relates to methods of modulating immune cells in a patient by altering microbiota of the patient. The invention also relates to methods of modulating treatments or therapies in a subject organism by altering microbiota of the subject. The invention also relates to cell populations, systems, arrays, cells, RNA, kits and other means for effecting this. In an example, advantageously selective targeting of a particular species in a human gut microbiota using guided nucleic acid modification is carried out to effect the alteration.Type: ApplicationFiled: April 19, 2019Publication date: August 8, 2019Applicant: SNIPR Technologies LimitedInventor: Jasper CLUBE
-
Patent number: 10363308Abstract: The invention relates to methods of modulating immune cells in a patient by altering microbiota of the patient. The invention also relates to methods of modulating treatments or therapies in a subject organism by altering microbiota of the subject. The invention also relates to cell populations, systems, arrays, cells, RNA, kits and other means for effecting this. In an example, advantageously selective targeting of a particular species in a human gut microbiota using guided nucleic acid modification is carried out to effect the alteration.Type: GrantFiled: November 15, 2018Date of Patent: July 30, 2019Assignee: SNIPR Technologies LimitedInventors: Jasper Clube, Morten Sommer, Christian Grøndahl
-
Patent number: 10300139Abstract: The invention relates to methods of modulating immune cells in a patient by altering microbiota of the patient. The invention also relates to methods of modulating treatments or therapies in a subject organism by altering microbiota of the subject. The invention also relates to cell populations, systems, arrays, cells, RNA, kits and other means for effecting this. In an example, advantageously selective targeting of a particular species in a human gut microbiota using guided nucleic acid modification is carried out to effect the alteration.Type: GrantFiled: July 20, 2018Date of Patent: May 28, 2019Assignee: SNIPR TECHNOLOGIES LIMITEDInventor: Jasper Clube
-
Patent number: 10300138Abstract: The invention relates to methods of modulating immune cells in a patient by altering microbiota of the patient. The invention also relates to methods of modulating treatments or therapies in a subject organism by altering microbiota of the subject. The invention also relates to cell populations, systems, arrays, cells, RNA, kits and other means for effecting this. In an example, advantageously selective targeting of a particular species in a human gut microbiota using guided nucleic acid modification is carried out to effect the alteration.Type: GrantFiled: July 5, 2018Date of Patent: May 28, 2019Assignee: SNIPR Technologies LimitedInventor: Jasper Clube
-
Publication number: 20190133135Abstract: The invention relates to methods, uses, systems, arrays, engineered nucleotide sequences and vectors for inhibiting bacterial population growth or for altering the relative ratio of sub-populations of first and second bacteria in a mixed population of bacteria. The invention is particularly useful, for example, for treatment of microbes such as for environmental, medical, food and beverage use. The invention relates inter alia to methods of controlling micro biologically influenced corrosion (MIC) or biofouling of a substrate or fluid in an industrial or domestic system.Type: ApplicationFiled: November 15, 2018Publication date: May 9, 2019Applicant: SNIPR Technologies LimitedInventor: Jasper CLUBE
-
Publication number: 20190134194Abstract: The invention relates to methods of modulating immune cells in a patient by altering microbiota of the patient. The invention also relates to methods of modulating treatments or therapies in a subject organism by altering microbiota of the subject. The invention also relates to cell populations, systems, arrays, cells, RNA, kits and other means for effecting this. In an example, advantageously selective targeting of a particular species in a human gut microbiota using guided nucleic acid modification is carried out to effect the alteration.Type: ApplicationFiled: November 15, 2018Publication date: May 9, 2019Applicant: SNIPR Technologies LimitedInventors: Jasper CLUBE, Morten SOMMER, Christian GRØNDAHL, Eric VAN DER HELM, Ruben VAZQUEZ-URIBE
-
Patent number: 10195273Abstract: The invention relates to methods of modulating immune cells in a patient by altering microbiota of the patient. The invention also relates to methods of modulating treatments or therapies in a subject organism by altering microbiota of the subject. The invention also relates to cell populations, systems, arrays, cells, RNA, kits and other means for effecting this. In an example, advantageously selective targeting of a particular species in a human gut microbiota using guided nucleic acid modification is carried out to effect the alteration.Type: GrantFiled: November 21, 2017Date of Patent: February 5, 2019Assignee: SNIPR TECHNOLOGIES LIMITEDInventor: Jasper Clube
-
Publication number: 20180303934Abstract: The invention relates to methods of modulating immune cells in a patient by altering microbiota of the patient. The invention also relates to methods of modulating treatments or therapies in a subject organism by altering microbiota of the subject. The invention also relates to cell populations, systems, arrays, cells, RNA, kits and other means for effecting this. In an example, advantageously selective targeting of a particular species in a human gut microbiota using guided nucleic acid modification is carried out to effect the alteration.Type: ApplicationFiled: July 5, 2018Publication date: October 25, 2018Applicant: SNIPR Technologies LimitedInventors: Jasper CLUBE, Morten SOMMER, Christian GRØNDAHL, Ruben VAZQUEZ-URIBE, Eric VAN DER HELM
-
Publication number: 20180146681Abstract: The invention relates to methods, uses, systems, arrays, engineered nucleotide sequences and vectors for inhibiting bacterial population growth or for altering the relative ratio of sub-populations of first and second bacteria in a mixed population of bacteria. The invention is particularly useful, for example, for treatment of microbes such as for environmental, medical, food and beverage use. The invention relates inter alia to methods of controlling microbiologically influenced corrosion (MIC) or biofouling of a substrate or fluid in an industrial or domestic system.Type: ApplicationFiled: January 4, 2018Publication date: May 31, 2018Applicant: SNIPR TECHNOLOGIES LIMITEDInventor: Jasper CLUBE
-
Publication number: 20180140698Abstract: The invention relates to methods of modulating immune cells in a patient by altering microbiota of the patient. The invention also relates to methods of modulating treatments or therapies in a subject organism by altering microbiota of the subject. The invention also relates to cell populations, systems, arrays, cells, RNA, kits and other means for effecting this. In an example, advantageously selective targeting of a particular species in a human gut microbiota using guided nucleic acid modification is carried out to effect the alteration.Type: ApplicationFiled: November 21, 2017Publication date: May 24, 2018Applicant: SNIPR TECHNOLOGIES LIMITEDInventors: Jasper CLUBE, Morten SOMMER, Christian GRØNDAHL, Ruben VAZQUEZ-URIBE, Eric VAN DER HELM
-
Publication number: 20180084786Abstract: The invention relates to methods, uses, systems, arrays, engineered nucleotide sequences and vectors for inhibiting bacterial population growth or for altering the relative ratio of sub-populations of first and second bacteria in a mixed population of bacteria. The invention is particularly useful, for example, for treatment of microbes such as for environmental, medical, food and beverage use. The invention relates inter alia to methods of controlling microbiologically influenced corrosion (MIC) or biofouling of a substrate or fluid in an industrial or domestic system.Type: ApplicationFiled: November 17, 2017Publication date: March 29, 2018Applicant: SNIPR TECHNOLOGIES LIMITEDInventor: Jasper CLUBE
-
Publication number: 20180084785Abstract: The invention relates to methods, uses, systems, arrays, engineered nucleotide sequences and vectors for inhibiting bacterial population growth or for altering the relative ratio of sub-populations of first and second bacteria in a mixed population of bacteria. The invention is particularly useful, for example, for treatment of microbes such as for environmental, medical, food and beverage use. The invention relates inter alia to methods of controlling microbiologically influenced corrosion (MIC) or biofouling of a substrate or fluid in an industrial or domestic system.Type: ApplicationFiled: November 17, 2017Publication date: March 29, 2018Applicant: SNIPR TECHNOLOGIES LIMITEDInventor: Jasper CLUBE
-
Publication number: 20180070594Abstract: The invention relates to methods, uses, systems, arrays, engineered nucleotide sequences and vectors for inhibiting bacterial population growth or for altering the relative ratio of sub-populations of first and second bacteria in a mixed population of bacteria. The invention is particularly useful, for example, for treatment of microbes such as for environmental, medical, food and beverage use. The invention relates inter alia to methods of controlling microbiologically influenced corrosion (MIC) or biofouling of a substrate or fluid in an industrial or domestic system.Type: ApplicationFiled: November 17, 2017Publication date: March 15, 2018Applicant: SNIPR TECHNOLOGIES LIMITEDInventors: Jasper CLUBE, Morten SOMMER, Christian GRØNDAHL, Eric VAN DER HELM, Ruben VAZQUEZ-URIBE
-
Publication number: 20180064115Abstract: The invention relates to methods, uses, systems, arrays, engineered nucleotide sequences and vectors for inhibiting bacterial population growth or for altering the relative ratio of sub-populations of first and second bacteria in a mixed population of bacteria. The invention is particularly useful, for example, for treatment of microbes such as for environmental, medical, food and beverage use. The invention relates inter alia to methods of controlling microbiologically influenced corrosion (MIC) or biofouling of a substrate or fluid in an industrial or domestic system.Type: ApplicationFiled: November 17, 2017Publication date: March 8, 2018Applicant: SNIPR TECHNOLOGIES LIMITEDInventors: Jasper CLUBE, Morten SOMMER, Christian GRØNDAHL, Eric VAN DER HELM, Ruben VAZQUEZ-URIBE
-
Publication number: 20180064114Abstract: The invention relates to methods, uses, systems, arrays, engineered nucleotide sequences and vectors for inhibiting bacterial population growth or for altering the relative ratio of sub-populations of first and second bacteria in a mixed population of bacteria. The invention is particularly useful, for example, for treatment of microbes such as for environmental, medical, food and beverage use. The invention relates inter alia to methods of controlling microbiologically influenced corrosion (MIC) or biofouling of a substrate or fluid in an industrial or domestic system.Type: ApplicationFiled: November 17, 2017Publication date: March 8, 2018Applicant: SNIPR TECHNOLOGIES LIMITEDInventor: Jasper CLUBE
-
Publication number: 20170246221Abstract: The invention relates to methods, uses, systems, arrays, engineered nucleotide sequences and vectors for inhibiting bacterial population growth or for altering the relative ratio of sub-populations of first and second bacteria in a mixed population of bacteria. The invention is particularly useful, for example, for treatment of microbes such as for environmental, medical, food and beverage use. The invention relates inter alia to methods of controlling microbiologically influenced corrosion (MIC) or biofouling of a substrate or fluid in an industrial or domestic system.Type: ApplicationFiled: April 4, 2017Publication date: August 31, 2017Applicant: SNIPR TECHNOLOGIES LIMITEDInventors: Jasper CLUBE, Morten SOMMER, Christian GRØNDAHL, Eric VAN DER HELM, Ruben VAZQUEZ-URIBE
-
Publication number: 20170196225Abstract: The invention relates to methods, uses, systems, arrays, engineered nucleotide sequences and vectors for inhibiting bacterial population growth or for altering the relative ratio of sub-populations of first and second bacteria in a mixed population of bacteria. The invention is particularly useful, for example, for treatment of microbes such as for environmental, medical, food and beverage use. The invention relates inter alia to methods of controlling microbiologically influenced corrosion (MIC) or biofouling of a substrate or fluid in an industrial or domestic system.Type: ApplicationFiled: March 16, 2017Publication date: July 13, 2017Applicant: SNIPR TECHNOLOGIES LIMITEDInventors: Jasper CLUBE, Morten SOMMER, Christian GRØNDAHL, Eric VAN DER HELM, Ruben VAZQUEZ-URIBE